Physician profile
Angelo Argento
NPI 1467408831
$1,417.82
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $193 · 2021: $205 · 2022: $464 · 2023: $78.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $299.26 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $218.04 | 2019-2023 | Tezspire |
| Sunovion Pharmaceuticals INC. | $98.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.59 | 2021-2022 | |
| Ethicon INC. | $97.03 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $89.54 | 2021-2023 | Glassia |
| Philips North America LLC | $59.37 | 2022 | |
| Merck Sharp & Dohme LLC | $49.74 | 2019-2021 | |
| Insulet Corporation | $43.43 | 2021-2022 | |
| Grifols USA, LLC | $42.04 | 2019-2020 | |
| Mylan Specialty L.P. | $41.23 | 2019-2022 | |
| Pfizer INC. | $29.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.10 | 2019 | |
| Biomerieux INC | $25.14 | 2019 | |
| Ani Pharmaceuticals, INC. | $24.25 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $23.43 | 2022 | |
| Scilex Pharmaceuticals INC. | $22.34 | 2021 | |
| Novo Nordisk INC | $19.89 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.67 | 2020 | |
| Exact Sciences Corporation | $18.73 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $17.44 | 2023 | Intellis Adaptivestim |
| Amgen INC. | $14.60 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.09 | 2019 | |
| Abbott Laboratories | $14.02 | 2022 | |
| Insmed, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Argento listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.